The public comment period is currently closed.
We thank the diverse stakeholders from the Parkinson’s community that contributed commentary on the draft Roadmap for Treatments that Make a Difference in Parkinson’s Disease document to inform the final version of this important work.
The goal of the Roadmap document is to provide researchers and the biopharmaceutical industry with a potentially more effective path to developing new therapies. Specifically, we hope to increase the efficiency and meaningfulness of clinical trials for new Parkinson’s treatments.
There continues to be huge unmet need for new treatments for Parkinson’s, particularly those that could prevent or slow disease progression. The Michael J. Fox Foundation is focused on increasing the number of potential therapies in development and move those therapies to patients faster.
To receive updates on the Roadmap as well as other scientific communications from The Michael J. Fox Foundation, please sign-up below.